Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 680 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Antibiotic Therapy Clear all

Conditions: Infectious Disease
Interventions: Not listed
Lead sponsor: Midwestern University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Postoperative Wound Infection-deep, Post Operative Wound Infection
Interventions: RUT058-60, Sterile saline for irrigation; Drug
Lead sponsor: Pulmatrix Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Mobile, Alabama • La Jolla, California • Houston, Texas + 1 more

Conditions: Osteomyelitis
Interventions: Dalbavancin, Standard of Care; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Ft. Pierce, Florida

Conditions: Pouchitis, Ileal Pouchitis, Ileal Pouch
Interventions: Tofacitinib 10 mg; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Polycystic Ovarian Syndrome (PCOS), Irregular Menstrual Cycles, Androgen Excess
Interventions: doxycycline, Sugar Pill; Drug · Other
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Obesity, Induction of Labor Affected Fetus / Newborn
Interventions: Cefazolin, Placebo, Azithromycin; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 15 Years to 45 Years · Female only
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Acute Respiratory Infection, Viral Infection, Upper Respiratory Tract Infections
Interventions: SPOTFIRE R Panel; Device
Lead sponsor: Christopher Payette; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Infection, Surgery, Nervous System Diseases
Interventions: Vancomycin; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 1,103 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL
Interventions: denintuzumab mafodotin, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; Drug
Lead sponsor: Seagen Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 34
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • Duarte, California + 31 more

Conditions: Pneumonia, Skin and Soft Tissue (SST) Infection, Urinary Tract Infections (UTIs)
Interventions: Study Drug Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Days to 17 Years
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 10
States / cities: Birmingham, Alabama • Aurora, Colorado • Washington D.C., District of Columbia + 6 more

Conditions: Assisted Reproductive Technology, Antibiotic Prophylaxis, Embryo Transfer
Interventions: Withholding antibiotic prophylaxis; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 43 Years
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Clostridium Difficile-Associated Diarrhea, Clostridium Enterocolitis, Clostridium Difficile Diarrhea, Antibiotic-associated Colitis, Antibiotic-associated Diarrhea
Interventions: GT160-246; Drug
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 58
States / cities: Mobile, Alabama • Phoenix, Arizona • Tucson, Arizona + 50 more

Conditions: Osteomyelitis of Jaw
Interventions: Amoxicillin-clavulanate 875mg/125mg q12hrs, oral clindamycin 300mg q6hrs, Levofloxacin 750mg QID; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: PANS, PANDAS, Obsessive Compulsive Disorder (OCD)
Interventions: Azithromycin, Placebo; Drug
Lead sponsor: University of South Florida; Other
Eligibility: 4 Years to 14 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Mycobacterium Avium Intracellulare Complex (MAC)
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Respiratory Disease, Acute Respiratory Infection, Respiratory Infection, Upper Respiratory Infection
Interventions: Online Tutorial, Webinars, Booster Sessions, Feedback Reports, Parent Survey; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Months to 10 Years
Enrollment: 2,728 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 20
States / cities: Paragould, Arkansas • Eureka, California • Durango, Colorado + 16 more

Conditions: Refractory Bone or Joint Infections
Interventions: sodium fusidate; Drug
Lead sponsor: Arrevus Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 19
States / cities: Fountain Valley, California • San Dimas, California • Sylmar, California + 16 more

Conditions: Helicobacter Pylori
Interventions: EnteroTracker(R) EST; Diagnostic Test
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiac Surgery, Sternal Wound Infection
Interventions: gentamicin-collagen sponge dipped in saline; Drug
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years and older
Enrollment: 1,502 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 43
States / cities: Birmingham, Alabama • Florence, Alabama • Pasadena, California + 39 more

Conditions: Open tíbia Fracture, Osteomyelitis Tibia, Tibial Fractures
Interventions: Vancomycin Hydrochloride, Gentamicin, Standard Intramedullary Nail; Drug · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 12
States / cities: Los Angeles, California • Macon, Georgia • Chicago, Illinois + 9 more

Conditions: Surgical Site Infection
Interventions: Mepilex Border Post-Op Ag, Standard Postoperative Dressing; Device
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: HIV Infections, Tuberculosis
Interventions: Cycloserine, Ethionamide, Capreomycin sulfate, Aminosalicylic acid, Streptomycin sulfate, Ethambutol hydrochloride, Amikacin sulfate, Isoniazid, Pyrazinamide, Pyridoxine hydrochloride, Levofloxacin, Rifampin, Clofazimine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 13 Years and older
Enrollment: 525 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 1998
U.S. locations: 21
States / cities: Chicago, Illinois • Detroit, Michigan • Brooklyn, New York + 2 more

Conditions: Sepsis, Procalcitonin, Antimicrobial Stewardship
Interventions: Procalcitonin-Guided Antimicrobial Stewardship, Baseline Antimicrobial Stewardship; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 2 Hours to 17 Years
Enrollment: 271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pneumocystis Carinii Pneumonia
Interventions: Antibiotics only, Antibiotics + Corticosteroids, Corticosteroids + antibiotics; Drug
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use

A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60

Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis

Tofacitinib For Treatment Of Chronic Pouchitis

Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)

Topical Vancomycin for Neurosurgery Wound Prophylaxis

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Trial of Reducing Inpatient Antibiotic Durations in Children

Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT

A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Efficacy of Oral vs IV Antibiotics in the Treatment of Orofacial Osteomyelitis

Antibiotic Treatment Trial for the PANDAS/PANS Phenotype

Mycobacterium Avium Intracellulare Complex (MAC) Study

Dialogue Around Respiratory Illness Treatment

Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections

Study of the Esophageal String Test (EST) for the Diagnosis of Helicobacter Pylori

Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection

Intramedullary Calcium Sulfate Antibiotic Depot

The Mepilex Cesarean Delivery Trial / MEPIDEL

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit

Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)